123 related articles for article (PubMed ID: 31136054)
1. High ductal proportion predicts biochemical recurrence in prostatic ductal adenocarcinoma.
Harkin T; Elhage O; Chandra A; Khan N; Kiberu Y; Frydenberg M; Dasgupta P
BJU Int; 2019 Dec; 124(6):907-909. PubMed ID: 31136054
[No Abstract] [Full Text] [Related]
2. Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer.
Murata Y; Tatsugami K; Yoshikawa M; Hamaguchi M; Yamada S; Hayakawa Y; Ueda K; Momosaki S; Sakamoto N
Int J Urol; 2018 Mar; 25(3):284-289. PubMed ID: 29315854
[TBL] [Abstract][Full Text] [Related]
3. Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens.
Seipel AH; Wiklund F; Wiklund NP; Egevad L
Virchows Arch; 2013 Apr; 462(4):429-36. PubMed ID: 23443941
[TBL] [Abstract][Full Text] [Related]
4. Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension.
Samaratunga H; Duffy D; Yaxley J; Delahunt B
Hum Pathol; 2010 Feb; 41(2):281-5. PubMed ID: 20004936
[TBL] [Abstract][Full Text] [Related]
5. Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival.
Chow K; Bedő J; Ryan A; Agarwal D; Bolton D; Chan Y; Dundee P; Frydenberg M; Furrer MA; Goad J; Gyomber D; Hanegbi U; Harewood L; King D; Lamb AD; Lawrentschuk N; Liodakis P; Moon D; Murphy DG; Peters JS; Ruljancich P; Verrill CL; Webb D; Wong LM; Zargar H; Costello AJ; Papenfuss AT; Hovens CM; Corcoran NM
Eur J Cancer; 2021 May; 148():440-450. PubMed ID: 33678516
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort.
Trudel D; Downes MR; Sykes J; Kron KJ; Trachtenberg J; van der Kwast TH
Eur J Cancer; 2014 Jun; 50(9):1610-6. PubMed ID: 24703897
[TBL] [Abstract][Full Text] [Related]
7. Prostatic ductal adenocarcinoma: a mini review.
Epstein JI
Med Princ Pract; 2010; 19(1):82-5. PubMed ID: 19996627
[TBL] [Abstract][Full Text] [Related]
8. Primary prostatic central zone adenocarcinoma.
Mai KT; Belanger EC; Al-Maghrabi HM; Robertson S; Wang D; Margnean C
Pathol Res Pract; 2008; 204(4):251-8. PubMed ID: 18178014
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of the Proportion of Ductal Component in Ductal Adenocarcinoma of the Prostate.
Jang WS; Shin SJ; Yoon CY; Kim MS; Kang DH; Kang YJ; Jeong WS; Cho NH; Choi YD
J Urol; 2017 Apr; 197(4):1048-1053. PubMed ID: 27916712
[TBL] [Abstract][Full Text] [Related]
10. Intraductal carcinoma of the prostate in the ejaculatory duct.
Sanchez-Salazar AJ; Basler JW; Nicolas MM
Int J Surg Pathol; 2010 Aug; 18(4):298-9. PubMed ID: 20444733
[TBL] [Abstract][Full Text] [Related]
11. [Ductal carcinoma of the prostate: impact on survival and therapeutic controversies of a rare tumor].
Finamanti M; Antonelli A; Contessa P; Cosciani Cunico S; Simeone C
Urologia; 2011; 78(4):283-7. PubMed ID: 22139802
[TBL] [Abstract][Full Text] [Related]
12. Large cystic ductal carcinoma of the prostate: imaging findings and minimally invasive surgical treatment.
Torricelli FC; Tucherman M; Melogno R; Coelho RF
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432907
[No Abstract] [Full Text] [Related]
13. Atypical ductal adenocarcinoma of the prostate with endometrioid immunohistological features.
Lucan M; Vasiliu V; Iacob G; Lucan V
Chirurgia (Bucur); 2009; 104(3):355-8. PubMed ID: 19601472
[TBL] [Abstract][Full Text] [Related]
14. Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type.
Au S; Villamil CF; Alaghehbandan R; Wang G
Ann Diagn Pathol; 2019 Apr; 39():59-62. PubMed ID: 30772651
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study.
Seipel AH; Samaratunga H; Delahunt B; Wiklund P; Clements M; Egevad L
APMIS; 2016 Apr; 124(4):263-70. PubMed ID: 26778368
[TBL] [Abstract][Full Text] [Related]
16. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases.
Lee S; Han JS; Chang A; Ross HM; Montironi R; Yorukoglu K; Lane Z; Epstein JI
Hum Pathol; 2013 Mar; 44(3):427-31. PubMed ID: 23026197
[TBL] [Abstract][Full Text] [Related]
17. Ductal adenocarcinoma of the prostate.
Shazer RL; Luthringer D; Agus DB; Gross ME
Clin Adv Hematol Oncol; 2004 Jun; 2(6):393-5; discussion 396. PubMed ID: 16163211
[No Abstract] [Full Text] [Related]
18. Pure prostatic papillary adenocarcinoma with ductal features.
Yamashita S; Inaba Y; Soma F; Katayama Y
Hinyokika Kiyo; 2005 Mar; 51(3):207-9; discussion 210. PubMed ID: 15852679
[TBL] [Abstract][Full Text] [Related]
19. Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study.
Knipper S; Preisser F; Mazzone E; Mistretta FA; Tian Z; Briganti A; Zorn KC; Saad F; Tilki D; Graefen M; Karakiewicz PI
Clin Genitourin Cancer; 2019 Jun; 17(3):231-237.e2. PubMed ID: 31080021
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical verification of ductal differentiation in prostate cancer.
Tarján M; Lenngren A; Hellberg D; Tot T
APMIS; 2012 Jun; 120(6):510-8. PubMed ID: 22583364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
